Michael Glantz - Concepedia

Author

Michael Glantz

Penn State Milton S. Hershey Medical Center ORCID

Also Known As

C. Weston, H.-M. Tseng, J. Sheehan, K. Rizzo, M Glantz, M J Glantz, M. Glantz, M. J. Glantz, M.J. Glantz, MICHAEL J. GLANTZ

353

Publications

14.4K

Citations

H-Index

111

Concepts

All Affiliations

Penn State Milton S. Hershey Medical Center Brown University University of Utah Pennsylvania State University University of Washington

About

Michael Glantz is an author at Penn State Milton S. Hershey Medical Center specializing in medicine, neuro-oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	36	2.4K
2	Health Sciences	13	13	739
3	Engineering	2	2	74
4	Nursing	1	1	49
5	Public Health	1	1	12

Michael Glantz

107

Publications

11.2K

Citations

H-Index

Page 1

	Year	Citations
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse W.K. Alfred Yung, Robert E. Albright, Jeffrey J. Olson, British Journal of Cancer	2000	932
Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED] Michael Glantz, Bernard F. Cole, Peter Forsyth, Neurology	2000	850
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Michael Glantz, Kurt A. Jaeckle, Marc C. Chamberlain, PubMed Neuro-oncologySurgical OncologyMedicineIntrathecal Sustained-release CytarabineCsf Disease	1999	526
Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme David A. Reardon, Karen Fink, Tom Mikkelsen, Journal of Clinical Oncology	2008	470
Cerebrospinal fluid cytology in patients with cancer Michael Glantz, Bernard F. Cole, Lisa Glantz, Cancer	1998	448
Anti‐Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer Francisco A. Luque, Henry Furneaux, R Ferziger, Annals of Neurology	1991	399
Randomized Trial of a Slow-Release Versus a Standard Formulation of Cytarabine for the Intrathecal Treatment of Lymphomatous Meningitis Michael Glantz, Suzanne LaFollette, Kurt A. Jaeckle, Journal of Clinical Oncology	1999	398
Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression Patricia Yee, Yiju Wei, Soo Yeon Kim, Nature Communications	2020	388
Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma Marc C. Chamberlain, Michael Glantz, Lisa Chalmers, Journal of Neuro-Oncology Neuro-oncologyRadiation TherapyNeurologyHigh-grade GliomasEarly Necrosis	2006	339
Treatment of radiation‐induced nervous system injury with heparin and warfarin Michael Glantz, P. C. Burger, Alon Friedman, Neurology	1994	326

Page 1